Over 2.3 million people worldwide are living with relapsing multiple sclerosis (RMS), and close to half of those are in the US. Unlike some other debilitating diseases, RMS impacts every patient ...

An index of gliosis was linked with persistent neurocognitive symptoms after mild or moderate SARS-CoV-2 infection, a small case-control study showed. Compared with healthy controls, PET measures of ...

With the coronavirus disease 2019 (COVID-19) pandemic, most infections are asymptomatic or mild, but a significant minority develop severe symptoms. Some earlier studies have indicated that initial ...

Cognitive impairment is a common but often overlooked symptom of schizophrenia. From difficulties in social settings to remembering how to take the bus to work, decreased cognitive function can ...

One of the biggest challenges in treating Alzheimer's disease (AD) is how heterogeneous it is in terms of speed of decline and presence of other pathologies. That is, more than 50% of people with AD ...

Samudyata has received funding from Hjarnfonden. Carl Sellgren receives funding from Swedish Research Council, Karolinska Institutet, the regional agreement on medical training and clinical research ...

Alzheimer's disease (AD) eventually leads to severe cognitive decline, but most affected individuals also develop distressing neuropsychiatric symptoms. These earlier effects may be more subtle and ...

"Our study suggests that identification of neuropsychiatric symptoms, such as depression, anxiety, agitation or delusions, could be crucial to distinguish MCI patients with risk of faster cognitive ...

Researchers have identified a new subtype of multiple sclerosis that affects thinking and memory rather than mobility — and as many as 26 percent of people with MS may have it. Researchers have ...

Covid-19 may be associated with cognitive decline and acceleration of Alzheimer’s-like symptoms, researchers reported Thursday. Researchers with an international consortium looking to understand the ...